Mild abdominal discomfort may resolve on its own
Nausea emerged in nearly four in ten people at higher doses in large studies, along with constipation and diarrhea
This option is for current GLP1 or weight loss medication patients looking to re-check labs, discuss dosing, discuss goals, etc
Roche with its 2024 acquisition of Carmot, and Pfizer, following its 2025 acquisition of Metsera, enter obesity and broaden their presence in cardiovascular/metabolic, while other large pharmaceutical companies prepare to follow later in the decade
Ward will follow up with you to track your results, assess the benefits of your injection, and adjust your care as needed
Whether you come to us for weight loss or an aesthetic treatment, we always have a long-term vision in mind